Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2008
11/27/2008US20080292635 Allergenic latex protein
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
11/27/2008US20080292633 Compositions and methods for the therapy and diagnosis of lung cancer
11/27/2008US20080292632 Irta2 Antibodies and Methods of Use
11/27/2008US20080292631 Treatment with anti-vegf antibodies
11/27/2008US20080292630 Treatment with anti-vegf antibodies
11/27/2008US20080292625 Prevention and treatment of cerebral amyloid angiopathy
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292621 Optimized Fc Variants and Methods for Their Generation
11/27/2008US20080292620 PRLR-Specific Antibody and Uses Thereof
11/27/2008US20080292619 Pharmaceutical Composition Containing Meltrin Antagonist
11/27/2008US20080292617 Antibody against a peptide derived from human mutant lamin a protein and uses thereof
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE102007024382A1 Diagnosing a neurodegenerative disease comprises the gene expression level of a specified marker in a biological sample
11/27/2008CA2688829A1 Novel rabbit antibody humanization methods and humanized rabbit antibodies
11/27/2008CA2688724A1 Novel simian t-cell lymphotropic virus
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2688146A1 Antibodies to il-6 and use thereof
11/27/2008CA2687903A1 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
11/27/2008CA2687791A1 Neutralizing antibodies
11/27/2008CA2687633A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/27/2008CA2687247A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
11/27/2008CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
11/27/2008CA2685049A1 Antibodies useful for therapy and diagnosis of cancer
11/27/2008CA2681480A1 Memory and learning impairments associated with disruption of ephrin receptor a6 (epha6) gene
11/27/2008CA2676028A1 Methods of determining lethality of pathogens and malignancies involving replikin peak genes
11/26/2008EP1995318A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995317A1 Mammalian cell surface antigens; related reagents
11/26/2008EP1995315A2 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/26/2008EP1995309A1 Recombinant protein production in avian EBx® cells
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994937A2 Prevention and treatment of amyloidogenic disease
11/26/2008EP1994824A1 Chimeric non-human animal
11/26/2008EP1994411A2 Truncated proteins as cancer markers
11/26/2008EP1994163A2 Inhibition of breast carcinoma stem cell growth and metastasis
11/26/2008EP1994157A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
11/26/2008EP1994146A1 Cancerous disease modifying antibody 141205-02
11/26/2008EP1994144A1 Human embryonic stem cell methods and podxl expression
11/26/2008EP1994057A2 Camptothecin-binding moiety conjugates
11/26/2008EP1994056A2 Antibodies to egfl7 and methods for their use
11/26/2008EP1994055A2 Anti-5t4 antibodies and uses thereof
11/26/2008EP1994053A1 Soluble gp130 molecule variants useful as a medicament
11/26/2008EP1993606A2 Immunoglobulins from vitiligo plasma for melanoma therapy
11/26/2008EP1993601A2 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
11/26/2008EP1993596A1 Cancer vaccine
11/26/2008EP1993593A1 Pharmaceutical compositions comprising sods and prolamine based peptide fragments
11/26/2008EP1434592B1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
11/26/2008EP1396539B1 Human-type anti-blood coagulation factor viii antibody
11/26/2008EP1257642B1 Partners of ptb1 domain of fe65, preparation and uses
11/26/2008EP1234574B1 Hair growth stimulant
11/26/2008EP1124953B1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
11/26/2008EP0865293B1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
11/26/2008EP0821732B1 Altered polypeptides with increased half-life
11/26/2008CN101313068A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
11/26/2008CN101313063A Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen
11/26/2008CN101312989A Monoclonal antibodies against claudin-18 for treatment of cancer
11/26/2008CN101312988A Antibody polypeptide library screening and selected antibody polypeptides
11/26/2008CN101312748A 抗体-药物轭合物和使用方法 Antibodies - drug conjugates and methods of use
11/26/2008CN101311191A Method for preparing immune globulin against lymphocyte of human
11/26/2008CN101310770A Antibodies against cancer
11/26/2008CN100436580C Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof
11/26/2008CN100436471C Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof
11/25/2008US7456264 Human monoclonal antibodies against Bacillus anthracis protective antigen
11/25/2008US7456263 P53 binding T cell receptor molecules
11/25/2008US7456262 Methods and composition for modulating and detecting wisp activity
11/25/2008US7456261 PRO9830 antibodies
11/25/2008US7456260 Humanized antibody
11/25/2008US7456259 Cancerous disease modifying antibodies
11/25/2008US7456258 Isolated monoclonal antibody produced by hybridoma deposit IDAC accession number 170505-03; binding bioassays; customization of therapy designed for each individual; anticarcinogenic-, -tumor and -metastasis agents
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456146 Anticarcinogenic agents for use in the treatment of cancer
11/25/2008US7456018 Human hepatoma lines, methods for obtaining same and uses thereof
11/25/2008US7455991 Serpentine transmembrane antigens expressed in human cancers and uses thereof
11/25/2008US7455989 AKAP84 and its use for visualization of biological structures
11/25/2008US7455977 Methods of determining the level of human TBP-II with anti-TBP-II antibody
11/25/2008US7455973 Independent of the patient's human papilloma virus (HPV) infection status by detecting biomarker(s) selectively overexpressed in high-grade cervical disease; kits
11/25/2008US7455962 Obtaining cells from the aorta-gonad-mesonephros region, detecting cells comprising a podocalyxin-like protein 1-positive phenotype (e.g., using an anti-PCLP1 antibody) and isolating them, and identifying from the isolated cells those having a CD45-negative phenotype
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008US7455836 Administering an agent which antagonizes the effects of a colony stimulating factor on these monocyte/macrophage cells to lower levels or reduce their activity; treating inflammation
11/25/2008US7455834 Methods and compositions for modulating and detecting WISP activity
11/25/2008US7455833 Antitumor, anticancer agents; complexing phosphatide with antibody, duramycin; prevent reproduction of virus
11/25/2008CA2274776C Method for analyzing annexin v in urine and use thereof
11/20/2008WO2008141285A2 Methods for early diagnosis of kidney disease
11/20/2008WO2008141278A1 Method for preparing antibody conjugates
11/20/2008WO2008141274A1 Anti-alpha v immunoliposome composition, methods and uses
11/20/2008WO2008141197A1 Chain reaction creating oligomers from repeat units of binding molecules
11/20/2008WO2008140653A2 Humaneered anti-factor b antibody
11/20/2008WO2008140639A2 Biomarkers and assays for alzheimer's disease
11/20/2008WO2008140603A2 METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING
11/20/2008WO2008140602A2 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN
11/20/2008WO2008140580A2 Specific antibody selection by selective elution conditions
11/20/2008WO2008140570A2 Antibody with protein a selectivity
11/20/2008WO2008140487A2 Improved staphylococcal protein a mono- and bispecific antibodies and methods of their use
11/20/2008WO2008140477A2 Hybrid immunoglobulins with moving parts
11/20/2008WO2008140415A1 H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
11/20/2008WO2008139202A1 Neutralizing monoclonal antibody against human dll4
1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 1494